News

Estee Lauder Companies Inc: Earnings Review and Insights Ahead

Estee Lauder Companies Inc: Earnings Review and Insights Ahead

Upcoming Earnings for Estee Lauder Companies Inc

Estee Lauder Companies Inc (NYSE: EL) is gearing up for its quarterly earnings announcement. Investors are keenly interested in the results, hoping for better-than-expected earnings and optimistic outlooks for future performance.

What to Anticipate in Earnings

Analysts forecast that Estee Lauder Companies Inc will report an earnings per share (EPS) of $0.09. The upcoming earnings report holds significant weight, as it can potentially influence the stock's trading momentum.

Many investors are hoping for positive news, particularly given the company’s recent trend of exceeding expectations during prior quarters. There's an anticipation of guidance that might indicate an upward shift in the company's financial trajectory, reflecting its response to market conditions.

Reviewing Past Earnings Performance

The performance in the last quarter was notably strong, where the company beat EPS estimates by $0.33, resulting in a 0.85% increase in the stock price the following day. This positive sentiment is pivotal as it sets the stage for investor confidence going into the upcoming earnings report.

Historically, Estee Lauder Companies has demonstrated resilience with better than expected earnings in the recent quarters:

Past Performance Overview

To better understand the company's consistency, here’s a brief overview of Estee Lauder Companies’ previous earnings and the corresponding effects on its share price:

Quarterly Earnings:

  • Q3 2025: EPS Estimate - 0.32, EPS Actual - 0.65, Price Change - +1.0%
  • Q2 2025: EPS Estimate - 0.32, EPS Actual - 0.62, Price Change - -5.0%
  • Q1 2025: EPS Estimate - 0.09, EPS Actual - 0.14, Price Change - -3.0%
  • Q4 2024: EPS Estimate - 0.28, EPS Actual - 0.64, Price Change - -2.0%

Current Market Performance

As of the most recent trading session, shares of Estee Lauder Companies Inc were priced at $90.74. Over the past 52 weeks, the stock has experienced a slight decline of 0.41%. This performance has left many long-term shareholders feeling concerned as they approach this imminent earnings announcement.

Market Sentiment on Estee Lauder Companies

Market analysts have provided a cumulative total of 13 ratings for Estee Lauder Companies Inc, with a consensus that currently suggests a Neutral outlook. The average one-year price target among analysts stands at $93.54, which points to a potential upside of approximately 3.09%.

Analyst Comparisons in the Beauty Industry

Gaining insights into Estee Lauder Companies’ standing relative to its competitors can provide investors with a clearer picture of market dynamics. Here’s a brief glance at competing firms such as Kenvue, e.l.f. Beauty, and Coty:

  • Kenvue: Neutral rating, estimated price target at $23.71, suggesting potential downside of -73.87%
  • e.l.f. Beauty: Buy rating, with a price target of $121.20 indicating a likely upside of +33.57%
  • Coty: Outperform rating, estimated price target of $12.00, suggesting down potential of -86.78%

Essential Metrics Summary

A comparative analysis of Estee Lauder and its peers unveils essential financial metrics:

CompanyConsensusRevenue GrowthGross ProfitReturn on Equity
Estee Lauder Companies IncNeutral-9.90%$2.66B3.74%
KenvueNeutral-4.03%$2.26B4.04%
e.l.f. BeautyBuy9.02%$244.54M4.26%
CotyOutperform-6.24%$832.40M-11.24%

Getting Acquainted with Estee Lauder Companies Inc

Estee Lauder is known as a prominent player in the global prestige beauty market, with significant offerings across skincare, makeup, fragrances, and hair care. The company operates various well-loved brands including Clinique, M.A.C, La Mer, and Jo Malone London, and reaches consumers through diverse channels including department stores and e-commerce platforms.

Key Financial Insights

Estee Lauder Companies holds a strong market presence, demonstrating confidence through significant market capitalization above industry averages.

Revenue Growth Observations: In the latest quarter, there was a revenue decline of approximately -9.9%. While this marks a setback, it's noteworthy that within the Consumer Staples sector, the company performed well compared to its peers.

Debt and Margin Performance: The net margin stands at 4.48%, indicating effective cost management. However, the company's debt-to-equity ratio of 2.16 suggests a substantial debt load that requires careful management.

Frequently Asked Questions

What are the earnings expectations for Estee Lauder Companies Inc?

Analysts expect an EPS of $0.09 for the upcoming earnings report.

How did Estee Lauder perform in previous quarters?

In the last quarter, Estee Lauder exceeded EPS estimates by $0.33, benefiting from a share price increase post-announcement.

What’s the current consensus rating for Estee Lauder?

The current consensus rating is Neutral, with an average price target of $93.54.

How do Estee Lauder's financial metrics compare with its peers?

Estee Lauder ranks well among its peers in gross profit and return on equity but faces challenges in revenue growth.

Which brands does Estee Lauder own?

Estee Lauder owns renowned brands like Clinique, M.A.C, and La Mer, covering a wide array of beauty products.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 337

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 130

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 148

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 121

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 197

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 201

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 152

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading

Top 5 Most Recently Viewed Articles

Mobility Direct's Inspiring Journey in Supporting the Disabled

Updated Category News Views 123

Empowering Mobility for a Decade Mobility Direct has reached a remarkable milestone, celebrating ten years of dedicated service to individuals facing mobility challenges. The company, based in Florida, has profoundly impacted the lives of many by providing free mobility scooters to those in need. With each scooter given, they challenge the common assumption that mobility...

Continue Reading
GARDANT GLOBAL Teams Up with GovConRx for Enhanced Services

Updated Category News Views 143

GARDANT GLOBAL Forms Strategic Alliance with GovConRx GARDANT GLOBAL is thrilled to share exciting news about its latest partnership with GovConRx. This collaboration is set to transform the landscape of contract performance management for government contractors. GovConRx, well-known for its expertise in enhancing CPARS ratings, will significantly augment GARDANT's...

Continue Reading
Text Request and Commify Join Forces to Enhance Messaging Solutions

Updated Category News Views 72

Text Request and Commify Join Forces to Enhance Messaging Solutions Text Request, a leader in the business text messaging domain, has recently announced an exciting new chapter following its acquisition by the U.K.-based Commify. This strategic move is aimed at expanding its reach within the U.S. market while maintaining its operational base in Chattanooga. Growth Journey...

Continue Reading
Agenus Investors Alerted on Class Action Lawsuit Developments

Updated Category News Views 64

Levi & Korsinsky Notifies Investors of Class Action for Agenus Inc. Levi & Korsinsky, LLP is reaching out to investors in Agenus Inc. (NASDAQ: AGEN) regarding a significant class action lawsuit that may impact those financially affected by the company's alleged misrepresentations. This development is crucial for stakeholders who have invested in Agenus during the...

Continue Reading
Savvas Unveils Innovative Science Curriculum for Students

Updated Category News Views 369

Introducing Experience Science for Grades K-8 In a groundbreaking initiative, Savvas Learning Company has launched Experience Science, an all-new program curated specifically for students in grades K-8. This innovative curriculum aims to engage young learners in scientific concepts, placing significant emphasis on hands-on experiences driven by real-world phenomena....

Continue Reading